GB2017087A - Process for the preparation of xanthone derivatives - Google Patents

Process for the preparation of xanthone derivatives

Info

Publication number
GB2017087A
GB2017087A GB7907543A GB7907543A GB2017087A GB 2017087 A GB2017087 A GB 2017087A GB 7907543 A GB7907543 A GB 7907543A GB 7907543 A GB7907543 A GB 7907543A GB 2017087 A GB2017087 A GB 2017087A
Authority
GB
United Kingdom
Prior art keywords
preparation
xanthone derivatives
image
carbon atoms
alkyl radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7907543A
Other versions
GB2017087B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roussel Laboratories Ltd
Original Assignee
Roussel Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Laboratories Ltd filed Critical Roussel Laboratories Ltd
Priority to GB7907543A priority Critical patent/GB2017087B/en
Publication of GB2017087A publication Critical patent/GB2017087A/en
Application granted granted Critical
Publication of GB2017087B publication Critical patent/GB2017087B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides

Abstract

A process for the preparation of compounds of general formula <IMAGE> (wherein R represents a hydrogen atom or an alkyl radical containing from 1 to 9 carbon atoms and R1 represents an alkyl radical containing from 1 to 5 carbon atoms) which comprises cyclising a compound of formula II, <IMAGE> (wherein R and R1 are defined above and R2 and R3, which may be the same or different, each represents an esterifying group) followed, if required, by hydrolysis to the free acid.
GB7907543A 1978-03-03 1979-03-02 Process for the preparation of xanthone derivatives Expired GB2017087B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7907543A GB2017087B (en) 1978-03-03 1979-03-02 Process for the preparation of xanthone derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB859578 1978-03-03
GB7907543A GB2017087B (en) 1978-03-03 1979-03-02 Process for the preparation of xanthone derivatives

Publications (2)

Publication Number Publication Date
GB2017087A true GB2017087A (en) 1979-10-03
GB2017087B GB2017087B (en) 1982-09-02

Family

ID=26242278

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7907543A Expired GB2017087B (en) 1978-03-03 1979-03-02 Process for the preparation of xanthone derivatives

Country Status (1)

Country Link
GB (1) GB2017087B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9796697B2 (en) 2015-06-12 2017-10-24 Peloton Therapeutics, Inc. Tricyclic inhibitors of HIF-2-alpha and uses thereof
US9884843B2 (en) 2013-12-16 2018-02-06 Peloton Therapeutics, Inc. Cyclic sulfone and sulfoximine analogs and uses thereof
US9896418B2 (en) 2013-09-09 2018-02-20 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US10155726B2 (en) 2015-03-11 2018-12-18 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10278942B2 (en) 2015-03-11 2019-05-07 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
US10335388B2 (en) 2015-04-17 2019-07-02 Peloton Therapeutics, Inc. Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US10512626B2 (en) 2015-03-11 2019-12-24 Peloton Therapeautics, Inc. Compositions for use in treating glioblastoma
US10807948B2 (en) 2015-03-11 2020-10-20 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
USRE49948E1 (en) 2022-02-03 2024-04-30 Peloton Therapeutics, Inc. Aryl ethers and uses thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10597366B2 (en) 2013-09-09 2020-03-24 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US9896418B2 (en) 2013-09-09 2018-02-20 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US9908845B2 (en) 2013-09-09 2018-03-06 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US9969689B2 (en) 2013-09-09 2018-05-15 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US10144711B2 (en) 2013-09-09 2018-12-04 Peloton Therapeutics, Inc. Aryl ethers and uses thereof
US9884843B2 (en) 2013-12-16 2018-02-06 Peloton Therapeutics, Inc. Cyclic sulfone and sulfoximine analogs and uses thereof
US10155726B2 (en) 2015-03-11 2018-12-18 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10278942B2 (en) 2015-03-11 2019-05-07 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
US10512626B2 (en) 2015-03-11 2019-12-24 Peloton Therapeautics, Inc. Compositions for use in treating glioblastoma
US10807948B2 (en) 2015-03-11 2020-10-20 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
US10335388B2 (en) 2015-04-17 2019-07-02 Peloton Therapeutics, Inc. Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US10786480B2 (en) 2015-04-17 2020-09-29 Peloton Therapeutics, Inc. Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof
US9796697B2 (en) 2015-06-12 2017-10-24 Peloton Therapeutics, Inc. Tricyclic inhibitors of HIF-2-alpha and uses thereof
USRE49948E1 (en) 2022-02-03 2024-04-30 Peloton Therapeutics, Inc. Aryl ethers and uses thereof

Also Published As

Publication number Publication date
GB2017087B (en) 1982-09-02

Similar Documents

Publication Publication Date Title
GB2017087A (en) Process for the preparation of xanthone derivatives
JPS5517386A (en) Novel oxadiazolopyrimidine derivative
ES8106289A1 (en) Derivatives of alpha-phenyl-2-pyrrolidine methanol and their salts, process for their preparation, use as medicines and compositions containing them.
ES8304971A1 (en) Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives.
AU8879482A (en) 4-acylamino-1-aza-adamantanes
GB2005246A (en) beta -Lactam compounds and processes for their preparation
GB2019843A (en) N-Alkenylmoranoline derivatives
SE8004622L (en) ACYLAMINOBENSOESYRADERIVAT
ES471267A1 (en) Lower alkyl 2-tri-(lower)alkylsilylacetylene-N-carbethoxyglycinates and process for using same
DE3363575D1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
GB2042540B (en) Process for the preparation of xanthone derivatives
ES8608538A1 (en) Process for the preparation of alfa-L-aspartyl-L-phenylalanine alkyl esters.
ES8401957A1 (en) Preparation of thiophene compounds
DE3267690D1 (en) Process for the preparation of 3-alkyl-6-methyl-beta-resorcylic-acid esters
SE7900889L (en) WAY TO PRODUCE XANTONE DERIVATIVES
AU551839B2 (en) Imidazolylcarboxylic acids and derivative
ES485801A1 (en) Process for preparing cyclo-1,3,2-oxazaphosphoryl derivatives
ES8102110A1 (en) 1,2,3-Thiadiazol-5-yl-thioglycolic acid, its derivatives and process for their preparation.
ES8206522A1 (en) Process for the Preparation of Apovincaminic Acid Esters
GB1482388A (en) Method of producing 6-beta-amidinopenicillanic acid derivatives
ES8104198A1 (en) Terephthalic acid monoamide derivatives, process for preparing the same, and an anti-allergic agent prepared from the same
ES465515A1 (en) Procedure for the obtaining of derivatives of acids 3,3&#39;triaril-metanodicarboxilicos. (Machine-translation by Google Translate, not legally binding)
ES471422A1 (en) Procedure for the preparation of amino alpha-acetylenic acids. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930302